Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.
暂无分享,去创建一个
Claudio Passino | Michele Emdin | Aldo Clerico | M. Emdin | F. Recchia | C. Passino | Fabio A Recchia | A. Clerico
[1] A. Ahluwalia,et al. Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms. , 2004, Basic research in cardiology.
[2] H. Imura,et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. , 1987, Circulation.
[3] G. Baxter. Natriuretic peptides and myocardial ischaemia , 2004, Basic Research in Cardiology.
[4] T. Yoshimoto,et al. Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. , 1994, The Journal of biological chemistry.
[5] Sprenkle,et al. Myocardial alpha-thrombin receptor activation induces hypertrophy and increases atrial natriuretic factor gene expression. , 1993, The Journal of biological chemistry.
[6] J. Winer,et al. Phenylephrine, endothelin, prostaglandin F2alpha' and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro. , 1998, Endocrine.
[7] M. Cowie,et al. BNP and congestive heart failure , 2003 .
[8] M. Esler,et al. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. , 2001, Journal of the American College of Cardiology.
[9] R. Sarzani,et al. The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects. , 1998, Journal of nephrology.
[10] G. Sagnella. Review: Vasopeptidase inhibitors , 2002 .
[11] H. Imura,et al. Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies. , 1993, The American journal of pathology.
[12] M. Redfield,et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. , 1998, American journal of physiology. Heart and circulatory physiology.
[13] A. Wu,et al. The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[14] M. Emdin,et al. Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure , 2004, Clinical chemistry and laboratory medicine.
[15] A. Friedman,et al. CORRELATION OF SERUM BRAIN NATRIURETIC PEPTIDE WITH HYPONATREMIA AND DELAYED ISCHEMIC NEUROLOGICAL DEFICITS AFTER SUBARACHNOID HEMORRHAGE , 2004, Neurosurgery.
[16] D. Morrow,et al. Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes: Ready for Clinical Application? , 2002, Circulation.
[17] H. H. Chen,et al. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. , 1998, Journal of cardiovascular pharmacology.
[18] A. Takeshita,et al. Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. , 2000, Journal of the American College of Cardiology.
[19] H. Büller,et al. Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism , 2003, Circulation.
[20] D. Giannessi,et al. Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: the need for a new generation of immunoassay methods. , 2000, Clinical chemistry.
[21] S. Kawashima,et al. PI 3-kinase-Akt-p70 S6 kinase in hypertrophic responses to leukemia inhibitory factor in cardiac myocytes. , 2003, The Kobe journal of medical sciences.
[22] J. Waschek. Developmental actions of natriuretic peptides in the brain and skeleton , 2004, Cellular and Molecular Life Sciences CMLS.
[23] A. Balduini,et al. Serum N-Terminal Pro–Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis , 2003, Circulation.
[24] A. Struthers,et al. Vasopeptidase inhibitors in heart failure. , 2002, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[25] M. Mehra,et al. B-Type Natriuretic Peptide in Heart Transplantation: An Important Marker of Allograft Performance , 2003, Heart Failure Reviews.
[26] A. Vollmar,et al. Co-expression of the natriuretic peptides (ANP, BNP, CNP) and their receptors in normal and acutely involuted rat thymus , 1995, Journal of Neuroimmunology.
[27] I. Hisatome,et al. Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure. , 2003, International journal of cardiology.
[28] M. Sabatine,et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. , 2004, Journal of the American College of Cardiology.
[29] G. Feuerstein,et al. Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure. , 1998, Journal of cardiovascular pharmacology.
[30] K. Pandey. Internalization and trafficking of guanylyl cyclase/natriuretic peptide receptor-A , 2005, Peptides.
[31] J. Stewart,et al. Contribution of the ventricles and the atrial appendages to the elevation of plasma atrial natriuretic factor (ANF) during pacing-induced heart failure in conscious dogs , 1996, Basic Research in Cardiology.
[32] A. Siani,et al. Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity. , 2004, Obesity research.
[33] A. Clerico. Pathophysiological and Clinical Relevance of Circulating Levels of Cardiac Natriuretic Hormones: Are They Merely Markers of Cardiac Disease? , 2002, Clinical chemistry and laboratory medicine.
[34] K. Yamaki,et al. Plasma concentrations of atrial, brain, and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory diseases. , 1996, Chest.
[35] J. Goetze. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. , 2004, Clinical chemistry.
[36] S. Ogawa,et al. Brain natriuretic peptide response is heterogeneous during β-blocker therapy for congestive heart failure , 2004 .
[37] R. Bataller,et al. Urinary excretion of urodilatin in patients with cirrhosis , 1996, Hepatology.
[38] T. Fukutomi,et al. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction. , 2004, The American journal of cardiology.
[39] R. Ziegler,et al. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells. , 1990, The Journal of pharmacology and experimental therapeutics.
[40] M. Valença,et al. Nitrergic modulation of vasopressin, oxytocin and atrial natriuretic peptide secretion in response to sodium intake and hypertonic blood volume expansion. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[41] B. Johnson,et al. Ectopic production and processing of atrial natriuretic peptide in a small cell lung carcinoma cell line and tumor from a patient with hyponatremia , 1997, Cancer.
[42] K. Nakao,et al. Angiotensin II-induced ventricular hypertrophy and extracellular signal-regulated kinase activation are suppressed in mice overexpressing brain natriuretic peptide in circulation. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[43] A. D. de Bold,et al. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. , 2004, Journal of molecular and cellular cardiology.
[44] M. Horiuchi,et al. Atrial natriuretic peptide and antihypertensive action due to beta-blockade in essential hypertensive patients. , 1995, Angiology.
[45] S. Murray,et al. Involvement of multiple cis elements in basal- and alpha-adrenergic agonist-inducible atrial natriuretic factor transcription. Roles for serum response elements and an SP-1-like element. , 1995, Circulation research.
[46] M. Weinmann. Natriuretic peptides and acute renal failure. , 1995, New horizons.
[47] T. Matsuda,et al. Local Expression of C-Type Natriuretic Peptide Suppresses Inflammation, Eliminates Shear Stress–Induced Thrombosis, and Prevents Neointima Formation Through Enhanced Nitric Oxide Production in Rabbit Injured Carotid Arteries , 2002, Circulation research.
[48] R. Nohara,et al. Neurohormonal determinants of peak oxygen uptake in patients with chronic heart failure. , 2003, Japanese heart journal.
[49] T. Takano,et al. Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter. , 2005, International journal of cardiology.
[50] S. Mudaliar,et al. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. , 2004, Journal of the American College of Cardiology.
[51] K. Bailey,et al. Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure. , 2005, American heart journal.
[52] R. McCuskey,et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[53] H. Ruskoaho. Cardiac hormones as diagnostic tools in heart failure. , 2003, Endocrine reviews.
[54] R. Moreau,et al. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis. , 1995, Journal of hepatology.
[55] B. Chaitman,et al. Antianginal efficacy of omapatrilat in patients with chronic angina pectoris. , 2005, The American journal of cardiology.
[56] H. Itoh,et al. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. , 1998, Journal of the American College of Cardiology.
[57] S. Kruger,et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism , 2004 .
[58] K. Margulies,et al. ANF-mediated renal cGMP generation in congestive heart failure. , 1991, The American journal of physiology.
[59] J. Rouleau,et al. Vasopeptidase inhibitors: potential role in the treatment of heart failure. , 2001, Heart failure monitor.
[60] K. Kangawa,et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. , 1998, American heart journal.
[61] K. Kangawa,et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. , 2000, Circulation.
[62] E. Levin,et al. Natriuretic peptides inhibit rat astroglial proliferation: mediation by C receptor. , 1991, The American journal of physiology.
[63] M. Hasumi,et al. Clinical significance of blood brain natriuretic peptide level measurement in the detection of heart disease in untreated outpatients: comparison of electrocardiography, chest radiography and echocardiography. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[64] A. Vollmar,et al. Immunomodulatory and cytoprotective function of atrial natriuretic peptide. , 2001, Critical reviews in immunology.
[65] C. Zanker,et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. , 2002, Journal of the American College of Cardiology.
[66] Y. Nakayama,et al. Local Delivery of Single Low-Dose of C-Type Natriuretic Peptide, an Endogenous Vascular Modulator, Inhibits Neointimal Hyperplasia in a Balloon-Injured Rabbit Iliac Artery Model , 2002, Journal of cardiovascular pharmacology.
[67] M. Hori,et al. Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure , 2001, Journal of hypertension.
[68] W. Forssmann,et al. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. , 1988, Circulation.
[69] P. Bettencourt. NT‐proBNP and BNP: biomarkers for heart failure management , 2004, European journal of heart failure.
[70] H. Itoh,et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. , 1995, Circulation.
[71] J. Pearlman,et al. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. , 2004, Journal of the American College of Cardiology.
[72] M. D. de Bold,et al. The physiological and pathophysiological modulation of the endocrine function of the heart. , 2001, Canadian journal of physiology and pharmacology.
[73] A. Vollmar,et al. Inhibition of cyclooxygenase-2 by natriuretic peptides. , 2002, Endocrinology.
[74] Douglas L Mann,et al. Stress-activated cytokines and the heart: from adaptation to maladaptation. , 2003, Annual review of physiology.
[75] E. Topol. Nesiritide - not verified. , 2005, The New England journal of medicine.
[76] D. Levy,et al. Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.
[77] M. Packer. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.
[78] T. Tokudome,et al. Direct effects of high glucose and insulin on protein synthesis in cultured cardiac myocytes and DNA and collagen synthesis in cardiac fibroblasts. , 2004, Metabolism: clinical and experimental.
[79] F. Smith,et al. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. , 1976, The Journal of clinical investigation.
[80] M. Quiñones,et al. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. , 2004, The American journal of cardiology.
[81] M. Vogeser,et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. , 2004, Journal of the American College of Cardiology.
[82] R. Freeman,et al. Captopril enhances renal responsiveness to ANF in dogs with compensated high-output heart failure. , 1992, The American journal of physiology.
[83] Simon G. Williams,et al. Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure. , 2004, The American journal of cardiology.
[84] K. Nakao,et al. Cosecretion of peptides derived from gamma‐human atrial natriuretic polypeptide in normal volunteers and patients with essential hypertension and adrenal disorders , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[85] T. Horio,et al. Stimulation of brain natriuretic peptide release from the heart by thyroid hormone. , 1993, Metabolism: clinical and experimental.
[86] K. Imataka,et al. Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension. , 1987, Hypertension.
[87] J. Marie,et al. Le degré de granulation des cardiocytes auriculaires. Etude planimétrique au cours de différents apports d'eau et de sodium chez le rat , 1976 .
[88] L. Wallentin,et al. Natriuretic peptides in unstable coronary artery disease. , 2004, European heart journal.
[89] J. Burnett,et al. Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases , 2002, Circulation research.
[90] M. Vatta,et al. B and C Types Natriuretic Peptides Modify Norepinephrine Uptake and Release in the Rat Adrenal Medulla , 1997, Peptides.
[91] B. Bruneau,et al. Mechanical and neuroendocrine regulation of the endocrine heart. , 1996, Cardiovascular research.
[92] K. Pandey. Biology of natriuretic peptides and their receptors , 2005, Peptides.
[93] D. Roth,et al. Natriuretic peptide gene expression after beta-adrenergic stimulation in adult mouse cardiac myocytes. , 2004, DNA and cell biology.
[94] M. Kuhn,et al. Calcium-dependent Dephosphorylation Mediates the Hyperosmotic and Lysophosphatidic Acid-dependent Inhibition of Natriuretic Peptide Receptor-B/Guanylyl Cyclase-B* , 2004, Journal of Biological Chemistry.
[95] P. McCullough,et al. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. , 2003, Reviews in cardiovascular medicine.
[96] A. Gundlach,et al. Ontogenic expression of natriuretic peptide mRNAs in postnatal rat brain: implications for development? , 1998, Brain research. Developmental brain research.
[97] A. Vollmar,et al. Expression and differential regulation of natriuretic peptides in mouse macrophages. , 1995, The Journal of clinical investigation.
[98] R. Troughton,et al. NT‐proBNP in heart failure: therapy decisions and monitoring , 2004, European journal of heart failure.
[99] P. Ivarsen,et al. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. , 1997, Scandinavian journal of clinical and laboratory investigation.
[100] K. Chien,et al. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. , 1991, The Journal of biological chemistry.
[101] P. Smits,et al. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. , 1993, Circulation.
[102] D. Wilber,et al. Retrograde fast pathway ablation for atrioventricular nodal reentry associated with markedly prolonged PR intervals. , 1999, The American journal of cardiology.
[103] S. Graziano,et al. Paraneoplastic syndromes associated with small cell lung cancer. , 1997, Chest surgery clinics of North America.
[104] C. Johnston,et al. Decreased Atrial Natriuretic Peptide Binding in Renal Medulla in Rats With Chronic Heart Failure , 1988, Circulation research.
[105] M. Foschi,et al. Blunted natriuretic response to low‐dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention , 1995, Hepatology.
[106] M. Boscaro,et al. Atrial natriuretic peptide in Cushing’s disease , 1990, Journal of endocrinological investigation.
[107] B. Kisch. Electron microscopy of the atrium of the heart. I. Guinea pig. , 1956, Experimental medicine and surgery.
[109] J. Born,et al. Intranasal atrial natriuretic peptide acts as central nervous inhibitor of the hypothalamo-pituitary-adrenal stress system in humans. , 2004, The Journal of clinical endocrinology and metabolism.
[110] M. Lapointe,et al. Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. , 1999, Hypertension.
[111] M. Drazner,et al. B-type natriuretic peptide in cardiovascular disease , 2003, The Lancet.
[112] M. Horiuchi,et al. Atrial Natriuretic Peptide and Antihypertensive Action Due to β-Blockade in Essential Hypertensive Patients , 1995 .
[113] R. Potthast,et al. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptors , 2005, Peptides.
[114] P. Urdal,et al. Serum N-terminal pro-atrial natriuretic factor 1-98 before and during thyroxine replacement therapy in severe hypothyroidism. , 1997, Thyroid : official journal of the American Thyroid Association.
[115] J. Tremblay,et al. Alteration of lung atrial natriuretic peptide receptors in genetic cardiomyopathy. , 1996, The American journal of physiology.
[116] A. Clerico,et al. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. , 2001, Clinical science.
[117] Andrew,et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.
[118] G. Schreiner,et al. B-Type Natriuretic Peptide Exerts Broad Functional Opposition to Transforming Growth Factor-&bgr; in Primary Human Cardiac Fibroblasts: Fibrosis, Myofibroblast Conversion, Proliferation, and Inflammation , 2004, Circulation research.
[119] T. Takano,et al. Plasma natriuretic peptide levels and daily physical activity in patients with pacemaker implantation. , 2001, Japanese heart journal.
[120] A. Ahluwalia,et al. Vascular actions of natriuretic peptides , 2004, Basic Research in Cardiology.
[121] H. Rickli,et al. Elevation of B-type natriuretic peptide levels in acute respiratory distress syndrome. , 2003, Swiss medical weekly.
[122] F. Cappuccio,et al. Raised plasma levels of atrial natriuretic peptides in Addison’s disease , 1989, Journal of endocrinological investigation.
[123] D. Wilson,et al. In vivo microperfusion of inner medullary collecting duct in rats: effect of amiloride and ANF. , 1990, The American journal of physiology.
[124] A. Haramati,et al. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure. , 1990, The American journal of physiology.
[125] J. Sadoshima,et al. Negative regulators of cardiac hypertrophy. , 2004, Cardiovascular research.
[126] T. Kato,et al. Pathogenesis of hyponatremia following subarachnoid hemorrhage due to ruptured cerebral aneurysm. , 1996, Surgical neurology.
[127] Douglas W Mahoney,et al. Plasma brain natriuretic peptide concentration: impact of age and gender. , 2002, Journal of the American College of Cardiology.
[128] M. Vatta,et al. B and C types natriuretic peptides modulate norepinephrine uptake and release in the rat hypothalamus , 1996, Regulatory Peptides.
[129] H. Kanauchi,et al. Resistance to Natriuresis in Patients with Peritonitis Carcinomatosa , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[130] G. Palade,et al. SPECIFIC GRANULES IN ATRIAL MUSCLE CELLS , 1964, The Journal of cell biology.
[131] J. Rehfeld,et al. Acute myocardial hypoxia increases BNP gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[132] A. Struthers,et al. Review: Vasopeptidase inhibitors in heart failure , 2002 .
[133] R. Latini,et al. Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts. , 2002, Journal of cardiac failure.
[134] A. D. de Bold,et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.
[135] M. McGrath,et al. Determinants of natriuretic peptide gene expression , 2005, Peptides.
[136] J. Winer,et al. Phenylephrine, endothelin, prostaglandin F2α, and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro, and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro , 1998, Endocrine.
[137] I. Hassinen,et al. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. , 1994, The American journal of physiology.
[138] G. Iervasi,et al. Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: how do they relate to the resistance to atrial natriuretic peptides? , 1995, Journal of cardiac failure.
[139] K. Werdan,et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction , 2003, Intensive Care Medicine.
[140] E. Frohlich,et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. , 2004, Journal of the American College of Cardiology.
[141] K. Nakao,et al. Effect of interleukin-1 beta on cardiac hypertrophy and production of natriuretic peptides in rat cardiocyte culture. , 1999, Journal of molecular and cellular cardiology.
[142] Robert,et al. Co-regulation of the Atrial Natriuretic Factor and Cardiac Myosin Light Chain-2 Genes during a-Adrenergic Stimulation of Neonatal Rat Ventricular Cells , 2001 .
[143] J. Kjekshus,et al. Differential responses of plasma atrial and brain natriuretic peptides to acute alteration in atrial pressure in pigs. , 2000, Scandinavian journal of clinical and laboratory investigation.
[144] N. Tamura,et al. Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[145] T. Marwick,et al. Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload. , 2004, American heart journal.
[146] R. Prywes,et al. p38 Mitogen-activated Protein Kinase Mediates the Transcriptional Induction of the Atrial Natriuretic Factor Gene through a Serum Response Element , 1998, The Journal of Biological Chemistry.
[147] D. Laky,et al. Electronmicroscopic observations regarding the presence of natriuretic granules in the ventricle of patients with cardiopathies. , 1997, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[148] P. Hildebrandt,et al. N‐terminal‐pro‐B‐type natriuretic peptide (NT‐pro‐BNP) in different thyroid function states , 2004, Clinical endocrinology.
[149] M. Tamaki,et al. Molecular forms of human brain natriuretic peptide in plasma. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[150] N. Alessandri,et al. Plasma atrial natriuretic hormone in hyperthyroidism. , 1998, Endocrine research.
[151] M. Kinoshita,et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. , 2001, Journal of the American College of Cardiology.
[152] Eva Pietrzak,et al. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. , 2004, Archives of internal medicine.
[153] S. Berti,et al. Altered tissue degradation and distribution of atrial natriuretic peptide in patients with idiopathic dilated cardiomyopathy and its relationship with clinical severity of the disease and sodium handling. , 1995, Circulation.
[154] A. Deten,et al. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. , 2002, Cardiovascular research.
[155] R. Califf,et al. Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) , 2002, Circulation.
[156] M. Bold. Estrogen, natriuretic peptides and the renin–angiotensin system , 1999 .
[157] R. Zimmerman,et al. Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. , 1988, The American journal of physiology.
[158] G. Sagnella. Vasopeptidase inhibitors. , 2002, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[159] H. Nawashiro,et al. Focal brain edema and natriuretic peptides in patients with subarachnoid hemorrhage , 2004, Journal of Clinical Neuroscience.
[160] C. Hennekens,et al. Brain natriuretic peptide: a potential marker for mortality in septic shock. , 2004, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[161] C. Benedict. Neurohumoral aspects of heart failure. , 1994, Cardiology clinics.
[162] M. Lapiński,et al. Plasma atrial natriuretic peptide concentration in patients with primary aldosteronism. , 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[163] M. Emdin,et al. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. , 2004, Clinical chemistry.
[164] A. Richards,et al. BNP in hormone-guided treatment of heart failure , 2002, Trends in Endocrinology & Metabolism.
[165] J. Rosado,et al. Expression and control of C-type natriuretic peptide in rat vascular smooth muscle cells. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[166] G. Brandenberger,et al. Mechanisms of renal hyporesponsiveness to ANP in heart failure , 2003, European journal of clinical investigation.
[167] J. Fray. Endocrine regulation of water and electrolyte balance , 2000 .
[168] A. Vollmar,et al. Inhibition of p38 MAPK Activation via Induction of MKP-1: Atrial Natriuretic Peptide Reduces TNF-&agr;–Induced Actin Polymerization and Endothelial Permeability , 2002, Circulation research.
[169] M. Andreassi,et al. Up‐regulation of ‘clearance’ receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones , 2001, European journal of heart failure.
[170] G. Ronnett,et al. Atrial Natriuretic Peptide Type C Induces a Cell-Cycle Switch from Proliferation to Differentiation in Brain-Derived Neurotrophic Factor- or Nerve Growth Factor-Primed Olfactory Receptor Neurons , 2002, The Journal of Neuroscience.
[171] N. Dalton,et al. Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy , 2000, Basic Research in Cardiology.
[172] J. Risteli,et al. Atrial natriuretic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction. , 2004, Journal of applied physiology.
[173] J. Herman,et al. Distribution of natriuretic peptide precursor mRNAs in the rat brain , 1995, The Journal of comparative neurology.
[174] M. Borggrefe,et al. Prognostic Value of Plasma N-Terminal Pro-Brain Natriuretic Peptide in Patients With Severe Sepsis , 2005, Circulation.
[175] K. Sugita,et al. Characterization of molecular forms of probrain natriuretic peptide in human plasma. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[176] M. Anand-Srivastava. Natriuretic peptide receptor-C signaling and regulation , 2005, Peptides.
[177] M. Borggrefe,et al. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. , 2005, Clinical laboratory.
[178] M. L. Kuroski de Bold. Estrogen, natriuretic peptides and the renin-angiotensin system. , 1999, Cardiovascular research.
[179] T. Ishizuka,et al. Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation , 2001, Regulatory Peptides.
[180] H. Nawata,et al. Cardiovascular, renal and endocrine effects of alpha-human atrial natriuretic peptide in patients with Cushing's syndrome and primary aldosteronism. , 1989, Journal of hypertension.
[181] I. Masuda,et al. Effects of cardiotrophin-1 on hemodynamics and endocrine function of the heart. , 2000, American journal of physiology. Heart and circulatory physiology.
[182] A. Richards,et al. Dendroaspis natriuretic peptide: endogenous or dubious? , 2002, The Lancet.
[183] K. Nakao,et al. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. , 1992, Frontiers in neuroendocrinology.
[184] S. Goldhaber,et al. Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism , 2003, Circulation.
[185] T. Walther,et al. Fibrosis rather than blood pressure determines cardiac BNP expression in mice , 2003, Regulatory Peptides.
[186] M. Vogeser,et al. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. , 2004, American journal of respiratory and critical care medicine.
[187] A. Vollmar,et al. ANP inhibits TNF‐α‐induced endothelial MCP‐1 expression—involvement of p38 MAPK and MKP‐1 , 2003 .
[188] J. Stypmann,et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. , 2004, Cardiovascular research.
[189] F. Boomsma,et al. Increased Plasma Concentration of Natriuretic Peptides by Selective &bgr;1-Blocker Bisoprolol , 2003, Journal of cardiovascular pharmacology.
[190] M. Vatta,et al. B-Type and C-Type Natriuretic Peptides Modify Norepinephrine Uptake in Discrete Encephalic Nuclei of the Rat , 2000, Cellular and Molecular Neurobiology.
[191] U. Dahlström. Can natriuretic peptides be used for the diagnosis of diastolic heart failure? , 2004, European journal of heart failure.
[192] A. Torbicki,et al. N‐terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism , 2003, European Respiratory Journal.
[193] L. R. Potter,et al. Down-Regulation Does Not Mediate Natriuretic Peptide-Dependent Desensitization of Natriuretic Peptide Receptor (NPR)-A or NPR-B: Guanylyl Cyclase-Linked Natriuretic Peptide Receptors Do Not Internalize , 2005, Molecular Pharmacology.
[194] A. D. de Bold,et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Reprinted from Life Sci. 28:89-94, 1981. , 2001, Journal of the American Society of Nephrology : JASN.
[195] G. Iervasi,et al. Turnover studies on cardiac natriuretic peptides: methodological, pathophysiological and therapeutical considerations. , 2000, Current drug metabolism.
[196] M. Kurabayashi,et al. Interleukin-6-Induced Reciprocal Expression of SERCA and Natriuretic Peptides mRNA in Cultured Rat Ventricular Myocytes , 2004, The Journal of international medical research.
[197] S. Ogawa,et al. Brain natriuretic peptide response is heterogeneous during beta-blocker therapy for congestive heart failure. , 2004, Journal of cardiac failure.
[198] A. Vollmar,et al. ANP inhibits TNF-alpha-induced endothelial MCP-1 expression--involvement of p38 MAPK and MKP-1. , 2003, Journal of leukocyte biology.
[199] N. Arakawa,et al. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population , 2002, Heart.